Filter by: patients
Home > Community Treatment Reports and Side Effects > human papillomavirus vaccine Treatment Report
What is human papillomavirus vaccine?

Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine is an inactivated vaccine used for the prevention of cervical, vulvar, and vaginal cancer, genital warts, cervical adenocarcinoma in situ, and vulvar, vaginal, or cervical intraepithelial neoplasia caused by HPV.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Prevent infection 1 0
RRP (Recurrent Respiratory Papillomatosis) 1 0
Family or personal history of autoimmune disease 1 0

Mouse over the table for more information

Reported Stop Reasons

Why Patients Stopped Taking human papillomavirus vaccine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 2   Course of treatment ended: 67%
Not indicated 2   Not indicated: 67%

See all 3 patients who’ve stopped taking human papillomavirus vaccine

Reported Duration See details about how long patients take this treatment ▼

Stopped Taking human papillomavirus vaccine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.